Genus-optimized strategy for the identification of chlamydial type III secretion substrates

被引:20
|
作者
Hovis, Kelley M. [1 ]
Mojica, Sergio [1 ]
McDermott, Jason E. [2 ]
Pedersen, Laura [1 ]
Simhi, Chana [1 ]
Rank, Roger G. [3 ]
Myers, Garry S. A. [4 ]
Ravel, Jacques [4 ]
Hsia, Ru-ching [5 ]
Bavoil, Patrik M. [1 ]
机构
[1] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA
[2] Pacific NW Natl Lab, Richland, WA 99352 USA
[3] Arkansas Childrens Hosp, Res Inst, Little Rock, AR 72202 USA
[4] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA
[5] Univ Maryland, Sch Dent, Core Imaging Facil, Baltimore, MD 21201 USA
来源
PATHOGENS AND DISEASE | 2013年 / 69卷 / 03期
基金
美国国家卫生研究院;
关键词
Chlamydia; type III secretion; effector; YERSINIA-PSEUDOTUBERCULOSIS; TRANSLOCATED PROTEIN; PNEUMONIAE; INFECTION; CYCLE; LOCALIZATION; CHAPERONES; EXPRESSION; PREDICTION; DEATH;
D O I
10.1111/2049-632X.12070
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Among chlamydial virulence factors are the type III secretion (T3S) system and its effectors. T3S effectors target host proteins to benefit the infecting chlamydiae. The assortment of effectors, each with a unique function, varies between species. This variation likely contributes to differences in host specificity and disease severity. A dozen effectors of Chlamydia trachomatis have been identified; however, estimates suggest that more exist. A T3S prediction algorithm, SVM-based Identification and Evaluation of Virulence Effectors (SIEVE), along with a Yersinia surrogate secretion system helped to identify a new T3S substrate, CT082, which rather than functioning as an effector associates with the chlamydial envelope after secretion. SIEVE was modified to improve/expand effector predictions to include all sequenced genomes. Additional adjustments were made to the existing surrogate system whereby the N terminus of putative effectors was fused to a known effector lacking its own N terminus and was tested for secretion. Expansion of effector predictions by cSIEVE and modification of the surrogate system have also assisted in identifying a new T3S substrate from C.psittaci. The expanded predictions along with modifications to improve the surrogate secretion system have enhanced our ability to identify novel species-specific effectors, which upon characterization should provide insight into the unique pathogenic properties of each species. The manuscript describes the application of new algorithms for computational discovery of type III secretion substrates in Chlamydiae, a group of pathogenic bacteria with limited experimental tools available for virulence gene discovery.
引用
收藏
页码:213 / 222
页数:10
相关论文
共 50 条
  • [31] Chlamydial Type III Secretion System Needle Protein Induces Protective Immunity against Chlamydia muridarum Intravaginal Infection
    Koroleva, Ekaterina A.
    Kobets, Natalie V.
    Shcherbinin, Dmitrii N.
    Zigangirova, Naylia A.
    Shmarov, Maxim M.
    Tukhvatulin, Amir I.
    Logunov, Denis Y.
    Naroditsky, Boris S.
    Gintsburg, Alexander L.
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [32] Pre-clinical pharmacokinetics and anti-chlamydial activity of salicylidene acylhydrazide inhibitors of bacterial type III secretion
    Ur-Rehman, Tofeeq
    Slepenkin, Anatoly
    Chu, Hencelyn
    Blomgren, Anders
    Dahlgren, Markus K.
    Zetterstrom, Caroline E.
    Peterson, Ellena M.
    Elofsson, Mikael
    Gylfe, Asa
    JOURNAL OF ANTIBIOTICS, 2012, 65 (08): : 397 - 404
  • [33] Pre-clinical pharmacokinetics and anti-chlamydial activity of salicylidene acylhydrazide inhibitors of bacterial type III secretion
    Tofeeq Ur-Rehman
    Anatoly Slepenkin
    Hencelyn Chu
    Anders Blomgren
    Markus K Dahlgren
    Caroline E Zetterström
    Ellena M Peterson
    Mikael Elofsson
    Åsa Gylfe
    The Journal of Antibiotics, 2012, 65 : 397 - 404
  • [34] Chlamydial type III secretion system is encoded on ten operons preceded by sigma 70-like promoter elements
    Hefty, P. Scott
    Stephens, Richard S.
    JOURNAL OF BACTERIOLOGY, 2007, 189 (01) : 198 - 206
  • [35] Transcriptional regulation of the Yts1 type II secretion system of Yersinia enterocolitica and identification of secretion substrates
    Shutinoski, Bojan
    Schmidt, M. Alexander
    Heusipp, Gerhard
    MOLECULAR MICROBIOLOGY, 2010, 75 (03) : 676 - 691
  • [36] Large-scale identification and translocation of type IV secretion substrates by Coxiella burnetii
    Chen, Chen
    Banga, Simran
    Mertens, Katja
    Weber, Mary M.
    Gorbaslieva, Ivana
    Tan, Yunhao
    Luo, Zhao-Qing
    Samuel, James E.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (50) : 21755 - 21760
  • [37] Identification of CesT, a chaperone for the type III secretion of Tir in enteropathogenic Escherichia coli
    Elliott, SJ
    Hutcheson, SW
    Dubois, MS
    Mellies, JL
    Wainwright, LA
    Batchelor, M
    Frankel, G
    Knutton, S
    Kaper, JB
    MOLECULAR MICROBIOLOGY, 1999, 33 (06) : 1176 - 1189
  • [38] Identification of YsaP, the Pilotin of the Yersinia enterocolitica Ysa Type III Secretion System
    Rau, Reina
    Darwin, Andrew J.
    JOURNAL OF BACTERIOLOGY, 2015, 197 (17) : 2770 - 2779
  • [39] Antibacterial Flavonoids from Medicinal Plants Covalently Inactivate Type III Protein Secretion Substrates
    Tsou, Lun K.
    Lara-Tejero, Maria
    RoseFigura, Jordan
    Zhang, Zhenrun J.
    Wang, Yen-Chih
    Yount, Jacob S.
    Lefebre, Matthew
    Dossa, Paul D.
    Kato, Junya
    Guan, Fulan
    Lam, Wing
    Cheng, Yung-Chi
    Galan, Jorge E.
    Hang, Howard C.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2016, 138 (07) : 2209 - 2218
  • [40] HrcQ Provides a Docking Site for Early and Late Type III Secretion Substrates from Xanthomonas
    Lorenz, Christian
    Hausner, Jens
    Buettner, Daniela
    PLOS ONE, 2012, 7 (11):